Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

Zhejiang Yatai Pharmaceutical Co., Ltd. (002370.SZ)

3.2600
+0.0500
+(1.56%)
As of 1:22:27 PM GMT+8. Market Open.
Loading Chart for 002370.SZ
  • Previous Close 3.2100
  • Open 3.2100
  • Bid 3.2500 x --
  • Ask 3.2600 x --
  • Day's Range 3.1900 - 3.2800
  • 52 Week Range 2.2100 - 4.3800
  • Volume 17,090,433
  • Avg. Volume 31,980,943
  • Market Cap (intraday) 2.431B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 81.50
  • EPS (TTM) 0.0400
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 10, 2019
  • 1y Target Est --

Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers solid dosage, cephalosporin powder injection, and freeze-dried powder injection products. Zhejiang Yatai Pharmaceutical Co., Ltd. was founded in 1989 and is based in Shaoxing, China.

www.ytyaoye.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 002370.SZ

View More

Performance Overview: 002370.SZ

Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

002370.SZ
6.89%
SSE Composite Index (000001.SS)
0.06%

1-Year Return

002370.SZ
4.40%
SSE Composite Index (000001.SS)
7.07%

3-Year Return

002370.SZ
36.08%
SSE Composite Index (000001.SS)
11.60%

5-Year Return

002370.SZ
36.58%
SSE Composite Index (000001.SS)
15.69%

Compare To: 002370.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 002370.SZ

View More

Valuation Measures

Annual
As of 5/7/2025
  • Market Cap

    2.39B

  • Enterprise Value

    1.92B

  • Trailing P/E

    72.30

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.45

  • Price/Book (mrq)

    2.40

  • Enterprise Value/Revenue

    5.37

  • Enterprise Value/EBITDA

    35.63

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.25%

  • Return on Assets (ttm)

    -0.50%

  • Return on Equity (ttm)

    3.74%

  • Revenue (ttm)

    357.01M

  • Net Income Avi to Common (ttm)

    29.43M

  • Diluted EPS (ttm)

    0.0400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    776.79M

  • Total Debt/Equity (mrq)

    3.01%

  • Levered Free Cash Flow (ttm)

    312.91M

Research Analysis: 002370.SZ

View More

Company Insights: 002370.SZ

Research Reports: 002370.SZ

View More

People Also Watch